Pharmaceutical and Biotech Public Relations
Biotech, pharmaceutical and molecular medicine companies turn to Schwartz to enhance their market positions and brands through thoughtful strategy and creative public relations programs. From discovery to development to commercialization, Schwartz is uniquely able to provide PR services to a broad range of life sciences firms. We translate the science into stories that resonate with broad audiences by working intelligently with researchers, compassionately with patients and proactively with the media.
Just as superior science provides the competitive advantage for pharmaceutical and biotech companies, choosing the right life sciences PR agency can be the critical difference between marketing failure and success. Schwartz has perfected the science of media relations and orchestrates national PR campaigns that achieve objectives such as product and technology visibility, partnership and funding cultivation, clinical trial recruitment, pre-launch market conditioning, new product introductions, reimbursement advocacy, alliance-building and paving the way for successful liquidity events.
In addition to award-winning media relations and social media capabilities, we offer outstanding complementary services such as government relations/public affairs, media coaching, video production and a speakers’ bureau.
Schwartz has a track record of working with some of the most innovative companies in the life sciences sector to publicize their science, products and people. Both past and present, representative clients include emerging as well as established organizations such as Cepheid, PowderMed (acquired by Pfizer), Osiris Therapeutics, BayBio, Micromet, StemCells, Biogen, Caliper Life Sciences, BioMS Medical, Agencourt (acquired by Beckman Coulter), Southern Research Institute and West Pharmaceutical Services.
Information about our work with biotech-based diagnostics companies and with other healthcare organizations is available here. We look forward to hearing from you about your company’s PR requirements.